Elevated plasma and urinary concentrations of green tea catechins associated with improved plasma lipid profile in healthy Japanese women

Nutrition Research

Volumn 36, Issue 3, 2016, Pages 220-226

  Takechi, Ryusuke ^a,b,c   Alfonso, Helman ^b   Hiramatsu, Naoko ^d   Ishisaka, Akari ^d   Tanaka, Akira ^c   Tan, La'Belle ^b   Lee, Andy H ^b  

^a CURTIN UNIVERSITY   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c KAGAWA NUTRITION UNIVERSITY   (Japan)

^d UNIVERSITY OF HYOGO   (Japan)

Author keywords

Biomarker; Cardiovascular disease; Catechin; Diabetes; Green tea

Indexed keywords

C REACTIVE PROTEIN; CATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER; GALLOCATECHIN; GLUCOSE BLOOD LEVEL; PLANT EXTRACT; TEA;

ADULT; AGED; ARTICLE; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; JAPANESE (PEOPLE); LIPID ANALYSIS; LIPID BLOOD LEVEL; LIQUID CHROMATOGRAPHY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TANDEM MASS SPECTROMETRY; TEA; TRIACYLGLYCEROL BLOOD LEVEL; ADIPOSE TISSUE; ANALOGS AND DERIVATIVES; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CARDIOVASCULAR DISEASE; CHEMISTRY; GLUCOSE BLOOD LEVEL; JAPAN; METABOLISM; MIDDLE AGED; URINE;

ADIPOSE TISSUE; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CATECHIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; JAPAN; MIDDLE AGED; PLANT EXTRACTS; TEA; TRIGLYCERIDES;

EID: 84959185359     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2015.11.010     Document Type: Article

References (43)

1. Di Castelnuovo A., di Giuseppe R., Iacoviello L., de Gaetano G. Consumption of cocoa, tea and coffee and risk of cardiovascular disease. Eur J Intern Med 2012, 23:15-25.
2. Mineharu Y., Koizumi A., Wada Y., Iso H., Watanabe Y., Date C., et al. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health 2011, 65:230-240.
3. Zhang C., Qin Y.Y., Wei X., Yu F.F., Zhou Y.H., He J. Tea consumption and risk of cardiovascular outcomes and total mortality: a systematic review and meta-analysis of prospective observational studies. Eur J Epidemiol 2015, 30:103-113.
4. Ohmori R., Kondo K., Momiyama Y. Antioxidant beverages: green tea intake and coronary artery disease. Clin Med Insights Cardiol 2014, 8:7-11.
5. Yang W.S., Wang W.Y., Fan W.Y., Deng Q., Wang X. Tea consumption and risk of type 2 diabetes: a dose-response meta-analysis of cohort studies. Br J Nutr 2014, 111:1329-1339.
6. Yang C.S., Hong J. Prevention of chronic diseases by tea: possible mechanisms and human relevance. Annu Rev Nutr 2013, 33:161-181.
7. Potenza M.A., Marasciulo F.L., Tarquinio M., Tiravanti E., Colantuono G., Federici A., et al. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 2007, 292:E1378-E1387.
8. Sae-tan S., Grove K.A., Lambert J.D. Weight control and prevention of metabolic syndrome by green tea. Pharmacol Res 2011, 64:146-154.
9. Ortsater H., Grankvist N., Wolfram S., Kuehn N., Sjoholm A. Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice. Nutr Metab (Lond) 2012, 9:11.
10. Roghani M., Baluchnejadmojarad T. Chronic epigallocatechin-gallate improves aortic reactivity of diabetic rats: underlying mechanisms. Vascul Pharmacol 2009, 51:84-89.
11. Kim M.J., Ryu G.R., Chung J.S., Sim S.S., Min D.S., Rhie D.J., et al. Protective effects of epicatechin against the toxic effects of streptozotocin on rat pancreatic islets: in vivo and in vitro. Pancreas 2003, 26:292-299.
12. Ishisaka A., Ichikawa S., Sakakibara H., Piskula M.K., Nakamura T., Kato Y., et al. Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats. Free Radic Biol Med 2011, 51:1329-1336.
13. Williamson G., Dionisi F., Renouf M. Flavanols from green tea and phenolic acids from coffee: critical quantitative evaluation of the pharmacokinetic data in humans after consumption of single doses of beverages. Mol Nutr Food Res 2011, 55:864-873.
14. Mata-Bilbao Mde L., Andres-Lacueva C., Roura E., Jauregui O., Torre C., Lamuela-Raventos R.M. A new LC/MS/MS rapid and sensitive method for the determination of green tea catechins and their metabolites in biological samples. J Agric Food Chem 2007, 55:8857-8863.
15. Sapozhnikova Y. Development of liquid chromatography-tandem mass spectrometry method for analysis of polyphenolic compounds in liquid samples of grape juice, green tea and coffee. Food Chem 2014, 150:87-93.
16. Onakpoya I., Spencer E., Heneghan C., Thompson M. The effect of green tea on blood pressure and lipid profile: a systematic review and meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis 2014, 24:823-836.
17. Wu A.H., Spicer D., Stanczyk F.Z., Tseng C.C., Yang C.S., Pike M.C. Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women. Cancer Prev Res (Phila) 2012, 5:393-402.
18. Chen I.J., Liu C.Y., Chiu J.P., Hsu C.H. Therapeutic effect of high-dose green tea extract on weight reduction: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr 2015, [Epub ahead of print].
19. Miyazaki R., Kotani K., Ayabe M., Tsuzaki K., Shimada J., Sakane N., et al. Minor effects of green tea catechin supplementation on cardiovascular risk markers in active older people: a randomized controlled trial. Geriatr Gerontol Int 2013, 13:622-629.
20. Haidari F., Shahi M.M., Zarei M., Rafiei H., Omidian K. Effect of green tea extract on body weight, serum glucose and lipid profile in streptozotocin-induced diabetic rats. A dose response study. Saudi Med J 2012, 33:128-133.
21. Lisowska A., Stawinska-Witoszynska B., Bajerska J., Krzyzanowska P., Walkowiak J. Green tea influences intestinal assimilation of lipids in humans: a pilot study. Eur Rev Med Pharmacol Sci 2015, 19:209-214.
22. Juhel C., Armand M., Pafumi Y., Rosier C., Vandermander J., Lairon D. Green tea extract (AR25) inhibits lipolysis of triglycerides in gastric and duodenal medium in vitro. J Nutr Biochem 2000, 11:45-51.
23. Grove K.A., Sae-tan S., Kennett M.J., Lambert J.D. (-)-Epigallocatechin-3-gallate inhibits pancreatic lipase and reduces body weight gain in high fat-fed obese mice. Obesity (Silver Spring) 2012, 20:2311-2313.
24. Wang S., Noh S.K., Koo S.I. Green tea catechins inhibit pancreatic phospholipase A(2) and intestinal absorption of lipids in ovariectomized rats. J Nutr Biochem 2006, 17:492-498.
25. Koo S.I., Noh S.K. Phosphatidylcholine inhibits and lysophosphatidylcholine enhances the lymphatic absorption of alpha-tocopherol in adult rats. J Nutr 2001, 131:717-722.
26. Armand M., Pasquier B., Andre M., Borel P., Senft M., Peyrot J., et al. Digestion and absorption of 2 fat emulsions with different droplet sizes in the human digestive tract. Am J Clin Nutr 1999, 70:1096-1106.
27. Shishikura Y., Khokhar S., Murray B.S. Effects of tea polyphenols on emulsification of olive oil in a small intestine model system. J Agric Food Chem 2006, 54:1906-1913.
28. Kim J.J., Tan Y., Xiao L., Sun Y.L., Qu X. Green tea polyphenol epigallocatechin-3-gallate enhance glycogen synthesis and inhibit lipogenesis in hepatocytes. Biomed Res Int 2013, 2013:920128.
29. Murase T., Misawa K., Haramizu S., Hase T. Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway. Biochem Pharmacol 2009, 78:78-84.
30. Banerjee S., Ghoshal S., Porter T.D. Phosphorylation of hepatic AMP-activated protein kinase and liver kinase B1 is increased after a single oral dose of green tea extract to mice. Nutr Res 2012, 32:985-990.
31. Yasui K., Paeng N., Miyoshi N., Suzuki T., Taguchi K., Ishigami Y., et al. Effects of a catechin-free fraction derived from green tea on gene expression of enzymes related to lipid metabolism in the mouse liver. Biomed Res 2012, 33:9-13.
32. Ahmad R.S., Butt M.S., Sultan M.T., Mushtaq Z., Ahmad S., Dewanjee S., et al. Preventive role of green tea catechins from obesity and related disorders especially hypercholesterolemia and hyperglycemia. J Transl Med 2015, 13:79.
33. Uchiyama Y., Suzuki T., Mochizuki K., Goda T. Dietary supplementation with a low dose of (-)-epigallocatechin-3-gallate reduces pro-inflammatory responses in peripheral leukocytes of non-obese type 2 diabetic GK rats. J Nutr Sci Vitaminol (Tokyo) 2013, 59:541-547.
34. Takahashi M., Miyashita M., Suzuki K., Bae S.R., Kim H.K., Wakisaka T., et al. Acute ingestion of catechin-rich green tea improves postprandial glucose status and increases serum thioredoxin concentrations in postmenopausal women. Br J Nutr 2014, 112:1542-1550.
35. Naz S., Siddiqi R., Dew T.P., Williamson G. Epigallocatechin-3-gallate inhibits lactase but is alleviated by salivary proline-rich proteins. J Agric Food Chem 2011, 59:2734-2738.
36. Forester S.C., Gu Y., Lambert J.D. Inhibition of starch digestion by the green tea polyphenol, (-)-epigallocatechin-3-gallate. Mol Nutr Food Res 2012, 56:1647-1654.
37. Shimizu M., Kobayashi Y., Suzuki M., Satsu H., Miyamoto Y. Regulation of intestinal glucose transport by tea catechins. Biofactors 2000, 13:61-65.
38. Hossain S.J., Kato H., Aoshima H., Yokoyama T., Yamada M., Hara Y. Polyphenol-induced inhibition of the response of na(+)/glucose cotransporter expressed in Xenopus oocytes. J Agric Food Chem 2002, 50:5215-5219.
39. Lin C.L., Lin J.K. Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells. Mol Nutr Food Res 2008, 52:930-939.
40. Zhang Z.F., Li Q., Liang J., Dai X.Q., Ding Y., Wang J.B., et al. Epigallocatechin-3-O-gallate (EGCG) protects the insulin sensitivity in rat L6 muscle cells exposed to dexamethasone condition. Phytomedicine 2010, 17:14-18.
41. Steptoe A., Gibson E.L., Vuononvirta R., Hamer M., Wardle J., Rycroft J.A., et al. The effects of chronic tea intake on platelet activation and inflammation: a double-blind placebo controlled trial. Atherosclerosis 2007, 193:277-282.
42. Oyama J., Maeda T., Kouzuma K., Ochiai R., Tokimitsu I., Higuchi Y., et al. Green tea catechins improve human forearm endothelial dysfunction and have antiatherosclerotic effects in smokers. Circ J 2010, 74:578-588.
43. De Bacquer D., Clays E., Delanghe J., De Backer G. Epidemiological evidence for an association between habitual tea consumption and markers of chronic inflammation. Atherosclerosis 2006, 189:428-435.